Literature DB >> 30041235

A Randomized Trial Evaluating the Effect of 10 versus 20 Revolutions Inside the Lymph Node on the Diagnostic Yield of EBUS-TBNA in Subjects with Sarcoidosis.

Sahajal Dhooria1, Inderpaul Singh Sehgal1, Nalini Gupta2, Amanjit Bal3, Kuruswamy Thurai Prasad1, Ashutosh Nath Aggarwal1, Babu Ram1, Ritesh Agarwal1.   

Abstract

BACKGROUND: Endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) is the preferred modality for sampling intrathoracic lymph nodes in patients with suspected sarcoidosis. Whether the number of revolutions of the needle inside the lymph node while performing TBNA affects the diagnostic yield is unknown.
OBJECTIVES: The aim of this paper was to compare the yield of different numbers of needle revolutions (10 vs. 20) during EBUS-TBNA in sarcoidosis.
METHODS: Consecutive subjects with a clinicoradiological suspicion of sarcoidosis were randomized 1: 1 to undergo EBUS-TBNA with either 10 (group 1) or 20 revolutions (group 2). The primary and secondary outcomes were the diagnostic yield and adequacy of aspirates, respectively. Other outcomes were procedure duration, gross blood contamination of the aspirates, and safety of the procedure.
RESULTS: Of the 171 subjects screened, 150 (mean age 43.5 years; 47.3% women) were randomized. A mean of 2.8 (group 1: 2.8, group 2: 2.7; p = 0.37) lymph nodes were sampled per subject with a mean of 2.1 passes per node in each group (p = 0.60). Among 133 subjects finally diagnosed with sarcoidosis, there was no difference (p = 0.65) in the diagnostic yield of EBUS-TBNA between group 1 (52/65, 80.0%) and group 2 (57/68, 83.8%). Adequate aspirates were obtained in 96.9 and 97.1% of the subjects in groups 1 and 2, respectively (p = 1.00). There was no difference in the procedure duration, the proportion of subjects with grossly bloody specimens, or complications between the 2 groups.
CONCLUSIONS: The diagnostic yield and specimen adequacy were not different when EBUS-TBNA was performed with 10 or 20 revolutions in subjects with sarcoidosis.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  EBUS-TBNA; Endosonography; Granuloma; Tuberculosis

Mesh:

Year:  2018        PMID: 30041235     DOI: 10.1159/000490192

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

Review 1.  Processing and Reporting of Cytology Specimens from Mediastinal Lymph Nodes Collected using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A State-of-the-Art Review.

Authors:  Inderpaul Singh Sehgal; Nalini Gupta; Sahajal Dhooria; Ashutosh Nath Aggarwal; Karan Madan; Deepali Jain; Parikshaa Gupta; Neha Kawatra Madan; Arvind Rajwanshi; Ritesh Agarwal
Journal:  J Cytol       Date:  2020-04-02       Impact factor: 1.000

2.  Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield.

Authors:  David Fielding; Andrew J Dalley; Mahendra Singh; Lakshmy Nandakumar; Katia Nones; Vanessa Lakis; Haarika Chittoory; Kaltin Ferguson; Farzad Bashirzadeh; Michael Bint; Carl Pahoff; Jung Hwa Son; Alan Hodgson; Sowmya Sharma; David Godbolt; Kylie Coleman; Lenore Whitfield; Nicola Waddell; Sunil R Lakhani; Gunter Hartel; Peter T Simpson
Journal:  JTO Clin Res Rep       Date:  2022-08-30

3.  Endobronchial ultrasound-guided transbronchial needle aspiration in the economically disadvantaged: A retrospective analysis of 1582 individuals.

Authors:  Kuruswamy Thurai Prasad; Sahajal Dhooria; Inderpaul Singh Sehgal; Valliappan Muthu; Babu Ram; Nalini Gupta; Ashutosh Nath Aggarwal; Ritesh Agarwal
Journal:  Lung India       Date:  2018 Nov-Dec

Review 4.  Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): Technical Updates and Pathological Yield.

Authors:  Huzaifa A Jaliawala; Samid M Farooqui; Kassem Harris; Tony Abdo; Jean I Keddissi; Houssein A Youness
Journal:  Diagnostics (Basel)       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.